Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.280
+0.030 (2.40%)
At close: Nov 4, 2024, 4:00 PM
1.290
+0.010 (0.78%)
After-hours: Nov 4, 2024, 6:07 PM EST
Protalix BioTherapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 94 | 130 | 69 | 38 | 118 | 49 | |
Market Cap Growth | -36.49% | 87.08% | 83.20% | -68.02% | 143.46% | 5.47% | |
Enterprise Value | 73 | 115 | 82 | 26 | 141 | 89 | |
Last Close Price | 1.25 | 1.78 | 1.37 | 0.83 | 3.63 | 3.28 | |
PE Ratio | - | 20.54 | -4.42 | -1.33 | -16.22 | -2.66 | |
PS Ratio | 2.40 | 1.98 | 1.46 | 0.99 | 1.88 | 0.89 | |
PB Ratio | 3.21 | 3.87 | -6.52 | -6.28 | -4.38 | -0.69 | |
P/FCF Ratio | -20.51 | -52.64 | -2.71 | -3.23 | -4.43 | -2.44 | |
P/OCF Ratio | -31.59 | -98.52 | -2.78 | -3.68 | -4.54 | -2.51 | |
EV/Sales Ratio | 1.92 | 1.75 | 1.72 | 0.68 | 2.24 | 1.62 | |
EV/EBITDA Ratio | -4.71 | 9.86 | -6.85 | -1.34 | 35.08 | -9.73 | |
EV/EBIT Ratio | -4.31 | 10.98 | -6.28 | -1.27 | 51.93 | -8.26 | |
EV/FCF Ratio | -15.22 | -46.57 | -3.19 | -2.21 | -5.26 | -4.43 | |
Debt / Equity Ratio | 0.92 | 0.78 | -3.15 | -5.55 | -2.38 | -0.87 | |
Debt / EBITDA Ratio | - | 2.00 | - | - | 11.94 | - | |
Debt / FCF Ratio | -6.25 | -10.65 | -1.31 | -2.85 | -2.41 | -3.05 | |
Asset Turnover | 0.42 | 0.93 | 0.74 | 0.54 | 1.11 | 1.03 | |
Inventory Turnover | 1.28 | 1.28 | 1.13 | 1.05 | 1.02 | 1.30 | |
Quick Ratio | 0.95 | 1.11 | 0.84 | 1.29 | 0.48 | 0.58 | |
Current Ratio | 1.33 | 1.54 | 1.38 | 1.86 | 0.64 | 0.81 | |
Return on Equity (ROE) | -43.48% | 72.50% | - | - | - | - | |
Return on Assets (ROA) | -10.27% | 9.32% | -12.57% | -18.06% | 2.99% | -12.58% | |
Return on Capital (ROIC) | -15.44% | 15.81% | -32.36% | -39.47% | 12.11% | - | |
Earnings Yield | -15.98% | 6.40% | -21.50% | -72.80% | -5.50% | -37.55% | |
FCF Yield | -4.55% | -1.90% | -36.92% | -31.00% | -22.58% | -41.06% | |
Buyback Yield / Dilution | -12.82% | -70.04% | -9.81% | -51.43% | -96.44% | -0.85% | |
Total Shareholder Return | -12.82% | -70.04% | -9.81% | -51.43% | -96.44% | -0.85% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.